Sanofi Inaugurates New Flu Vaccine Facility In Canada

Sept. 16 (Reuters) - Sanofi SA SASY.PA:

• Sanofi inaugurates a new flu vaccine facility, described as Canada’s largest biomanufacturing investment.
• The investment totals CAD 925 million, including CAD 415 million in partnership from the Government of Canada and CAD 55 million from the Government of Ontario.
• The Charles Best building is expected to begin production in early 2027, pending regulatory approval, in preparation for the 2027-28 flu season.